PURPOSE: To assess the effect of nerve-sparing (NS) radical retropubic prostatectomy (RRP) on surgical margins and biochemical recurrence. PATIENTS AND METHODS: Location and incidence of positive surgical margins, recurrence, and time to recurrence were assessed in a consecutive series of 734 men who underwent RRP for localized prostate cancer from 1992 through February 2000. NS procedures were used in 33% (n = 240) of 734 patients studied. RESULTS: Surgical margins were positive for 24% (n = 58) and 31% (n = 152) of NS and non-NS patients, respectively (P =.06). No significant difference between the groups was found in location of positive margins (P =.92). Prostate-specific antigen level greater than 10 ng/mL, extraprostatic extension, tumor volume more than 20%, capsular penetration, Gleason score > or = 7, positive margins, and seminal vesicle invasion were associated with significantly increased risk of recurrence. However, NS patients were not at increased risk of recurrence compared with non-NS patients (hazard ratio, 0.96; 95% confidence interval, 0.53 to 1.72). The cumulative risk of recurrence within 3 and 5 years of surgery in NS patients was 9.7% and 14.4%, respectively, as compared with 17.1% and 21.1% for non-NS patients. CONCLUSION: In patients with localized prostate cancer, neither margin status nor biochemical-free survival within 5 years of surgery were altered by the nerve preservation technique. Given our experience, we recommend preservation of neurovascular bundles in these patients whenever the procedure is technically feasible.
PURPOSE: To assess the effect of nerve-sparing (NS) radical retropubic prostatectomy (RRP) on surgical margins and biochemical recurrence. PATIENTS AND METHODS: Location and incidence of positive surgical margins, recurrence, and time to recurrence were assessed in a consecutive series of 734 men who underwent RRP for localized prostate cancer from 1992 through February 2000. NS procedures were used in 33% (n = 240) of 734 patients studied. RESULTS: Surgical margins were positive for 24% (n = 58) and 31% (n = 152) of NS and non-NS patients, respectively (P =.06). No significant difference between the groups was found in location of positive margins (P =.92). Prostate-specific antigen level greater than 10 ng/mL, extraprostatic extension, tumor volume more than 20%, capsular penetration, Gleason score > or = 7, positive margins, and seminal vesicle invasion were associated with significantly increased risk of recurrence. However, NS patients were not at increased risk of recurrence compared with non-NS patients (hazard ratio, 0.96; 95% confidence interval, 0.53 to 1.72). The cumulative risk of recurrence within 3 and 5 years of surgery in NS patients was 9.7% and 14.4%, respectively, as compared with 17.1% and 21.1% for non-NS patients. CONCLUSION: In patients with localized prostate cancer, neither margin status nor biochemical-free survival within 5 years of surgery were altered by the nerve preservation technique. Given our experience, we recommend preservation of neurovascular bundles in these patients whenever the procedure is technically feasible.
Authors: Ashutosh K Tewari; Maria M Shevchuk; Joshua Sterling; Sonal Grover; Michael Herman; Rajiv Yadav; Kumaran Mudalair; Abhishek Srivastava; Mark A Rubin; Warren R Zipfel; Frederick R Maxfield; Chris Xu; Watt W Webb; Sushmita Mukherjee Journal: BJU Int Date: 2011-03-28 Impact factor: 5.588
Authors: Joseph L Chin; John Srigley; Linda A Mayhew; R Bryan Rumble; Claire Crossley; Amber Hunter; Neil Fleshner; Bish Bora; Robin McLeod; Sheila McNair; Bernard Langer; Andrew Evans Journal: Can Urol Assoc J Date: 2010-02 Impact factor: 1.862
Authors: Robert B Nadler; Jessica T Casey; Lee C Zhao; Neema Navai; Zachary L Smith; Ali Zhumkhawala; Amanda M Macejko Journal: J Robot Surg Date: 2009-11-19
Authors: Sultan Saud Alkhateeb; Shabbir M Alibhai; Antonio Finelli; Neil E Fleshner; Michael A Jewett; Alexandre R Zlotta; John Trachtenberg Journal: Urol Ann Date: 2010-05
Authors: Luke T Lavallée; Andrew Stokl; Sonya Cnossen; Ranjeeta Mallick; Chris Morash; Ilias Cagiannos; Rodney H Breau Journal: Can Urol Assoc J Date: 2016 Jan-Feb Impact factor: 1.862
Authors: J L Nelles; S J Freedland; J C Presti; M K Terris; W J Aronson; C L Amling; C J Kane Journal: Prostate Cancer Prostatic Dis Date: 2008-07-15 Impact factor: 5.554
Authors: David D Thiel; Ryan Hutchinson; Nancy Diehl; Andrea Tavlarides; Adrienne Williams; Alexander S Parker Journal: JSLS Date: 2012 Apr-Jun Impact factor: 2.172